Skip to main content

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

Projects

Disfunción autonómica y ritmo circadiano en el Síndrome de Fatiga Crónica/Encefalomielitis Miálgica: nuevas herramientas diagnósticas y terapéuticas en la enfermedad

IP: Jesus Castro Marrero
Collaborators: José Alegre Martin
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI19/00629
Duration: 01/01/2020 - 30/06/2024

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)

IP: Fco Javier Santos Vicente
Collaborators: Beatriz Lobo Alvarez, José Alegre Martin, Amanda Rodríguez Urrutia, Silvia Muñoz Caller, Carmen Alonso Cotoner, Jesus Castro Marrero, Natalia Rodriguez Santas, Ana Maria Gonzalez Castro, Marc Pigrau Pastor, Adoración Nieto Ruiz, Natalia Llonga Tejedor, Alejandro Henao Paez, Consuelo Cammarota
Funding agency: EUROPEAN COMMISSION
Funding: 1148684.84
Reference: DISCOVERIE_H2020-SC1-BHC_2019
Duration: 01/01/2020 - 31/05/2025

European Network on Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (EUROMENE)

IP: Jesus Castro Marrero
Collaborators: José Alegre Martin
Funding agency: EUROPEAN COMMISSION
Funding: 52000
Reference: EUROMENE_CA15111_COST2015
Duration: 21/04/2016 - 20/04/2020

Ensayo clínico, aleatorizado, controlado, paralelo, para evlauar la eficacia de dos técnicas de acupuntura validad en salud: Somatoacupuntura versus Auriculopuntura, como tratamiento en los pacientes diagnosticados con Síndrome de Fatiga Crónica

IP: -
Collaborators: José Alegre Martin
Funding agency: Col·legi Oficial d'Infermers/es de Barcelona
Funding: 2420
Reference: COIB-2725-12
Duration: 01/01/2013 - 31/12/2014

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Gerard Orriols Torras

Gerard Orriols Torras

Research technician
Pneumology
Read more
Francesc Rudilla Salvador

Francesc Rudilla Salvador

Senior researcher
Transfusional Medicine
Read more
Agustín Arasanz Duque

Agustín Arasanz Duque

Gestió i Administració
Internal Strategy Directorate
Read more
Helena Ramal Mollfulleda

Helena Ramal Mollfulleda

Cap d'Unitat
Infrastructure Coordination
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.